|
Affiliation |
Faculty of Medicine College Hospital Operation part |
|
Title |
Associate Professor |
|
External Link |
|
YANO Takeshi
|
|
|
Research Areas 【 display / non-display 】
-
Life Science / Emergency medicine
-
Life Science / Anesthesiology
Papers 【 display / non-display 】
-
Furusawa Takahiro, Yano Takeshi, Kashino Rina, Yoshikai Mizuho, Koshida Tomohiro, Yonaha Tetsu, Taniguchi Masahiko, Tsuneyoshi Isao
Journal of the Japanese Society of Intensive Care Medicine 30 ( 1 ) 23 - 24 2023.1
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Intensive Care Medicine
DOI： 10.3918/jsicm.30_23
-
透析用バスキュラーアクセスカテーテルが上行腰静脈に迷入し腸腰筋血腫を呈した１症例． Reviewed
古澤高廣，矢野武志，菓子野里奈，吉海瑞穂，越田智広，與那覇 哲，谷口正彦，恒吉勇男
日本集中治療医学会雑誌 30 ( 1 ) 23 - 24 2023.1
Language：Japanese Publishing type：Research paper (scientific journal)
-
Comparison of permeability and antithrombotic properties of two Polysulfone (PS) membranes Reviewed
Yamasaki Tatsumi, Adachi Nene, Oda Yuuichi, Yano Takeshi, Taniguchi Masahiko, Shirasaka Tetsuro
Journal of Japan Society for Blood Purification in Critical Care 13 ( 1 ) 64 - 68 2022.6
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japan Society for Blood Purification in Critical Care
In recent years, HEMOFEEL<sup>®</sup> SNV, in which an NV polymer is localized on the inner surface of the hollow fiber of a Polysulfone (PS) membrane hemofilter, has been sold. NV polymers are believed to have improved antithrombotic properties by suppressing protein adhesion (fouling). In order to investigate the permeability and antithrombotic properties of HEMOFEEL<sup>®</sup> SNV, we compared it with other companies’ PS membrane hemofilters. The subjects were 56 adult patients who underwent CHDF (continuous hemodiafiltration) using PS membrane hemofilters, and the number of membranes was 226. The patients were divided into the EXCELFLO<sup>®</sup> AEF-13 group and the HEMOFEEL<sup>®</sup> SNV-1.3 group, and the transmembrane pressure (TMP), ultrafiltration rate (UFR), and lifetime were compared. The results suggested that the HEMOFEEL<sup>®</sup> SNV-1.3 group had significantly lower TMP and significantly higher UFR, which was advantageous for high flow rate filtration settings.
-
Investigation of optimal ACT value during continuous hemodiafiltration using nafamostat mesilate Reviewed
Yamasaki Tatsumi, Oda Yuuichi, Yano Takeshi, Taniguchi Masahiko, Shirasaka Tetsuro
Journal of Japan Society for Blood Purification in Critical Care 12 ( 1 ) 58 - 63 2021.12
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japan Society for Blood Purification in Critical Care
Nafamostat mesilate (NM) was a first-choice drug used as an anticoagulant in continuous hemodiafiltration (CHDF) in our hospital. Activated clotting time (ACT) is an index of the dose of NM. The standard value of ACT is undecided, and blood coagulation in the circuit is occasionally observed. The purpose of this study was to investigate the optimal ACT value for continuous hemodiafiltration using NM. Forty-seven adult patients with scheduled CHDF using NM were included in this study. The ACT value of the outlet site (H-ACT) in the circuit of the hemofiltration device and the ACT value of arterial blood (A-HCT) were measured. There are significant differences (<i>P</i>＜ 0.001) in the H-ACT values between the group (346±94.1s) that continued hemodiafiltration for more than 48 hours and the group（261±92.5s）that stopped hemodiafiltration within 48 hours due to occlusion in the dialysis circuit. These results suggest that a higher H-ACT value lowers the risk of occlusion in the circuit. As analyzed by receiver operating characteristic (ROC) analysis, the cut-off value for the achievement of CHDF was 271 sec (specificity 69.6%, sensitivity 85.1%). These results suggest that H-ACT values of more than 271 sec are appropriate.
-
麻酔覚醒時のバッキングが原因と考えられた特発性縦隔気腫の１症例．
長嶺佳弘，矢野武志，森 信一郎，内村修二，與那覇 哲，江川久子，谷口正彦，恒吉勇男
麻酔 70 ( 8 ) 866 - 869 2021.8
Language：Japanese Publishing type：Research paper (scientific journal)
Books 【 display / non-display 】
-
麻酔偶発症A to Z
矢野武志（ Role： Contributor）
文光堂 2017.6
Responsible for pages：475-476 Language：Japanese Book type：Scholarly book
-
麻酔偶発症A to Z
矢野武志（ Role： Contributor , 仙骨麻酔の失敗（効果なし）・不完全ブロック．）
文光堂 2017.6
Responsible for pages：434-435 Language：Japanese Book type：Scholarly book
-
麻酔科医のための周術期の薬物使用法-イソプレナリン
谷口正彦, 矢野武志, 恒吉勇男（ Role： Joint author , 全身管理薬ーイソプレナリン pp206-208）
中山書店 2015.4
Language：Japanese Book type：Scholarly book
MISC 【 display / non-display 】
-
Yano T., Uchimura S., Nagahama M., Yonaha T., Taniguchi M., Tsuneyoshi I.
Journal of Clinical Anesthesia 55 144 - 145 2019.8
Language：English Publishing type：Article, review, commentary, editorial, etc. (bulletin of university, research institution) Publisher：Journal of Clinical Anesthesia
-
Food choking in a patient with congenital temporomandibular joint ankylosis
Yano T., Taniguchi M., Tsuneyoshi I.
Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi 45 ( 6 ) 380 - 381 2017.12
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (bulletin of university, research institution) Publisher：Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi
-
Analysis of the alarms from a blood purification machine during continuous haemodiafiltration
Yano T., Fukumoto H., Taniguchi M., Tsuneyoshi I.
Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi 45 ( 4 ) 237 - 238 2017
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (bulletin of university, research institution) Publisher：Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi
-
デスフルランの上手な使い方 各科手術での使用：高齢者手術―高齢者への応用の長所・短所―． Reviewed
矢野武志，恒吉勇男
日本臨床麻酔学会誌 36 ( 4 ) 479 - 483 2016.7
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal)
-
Continuous rocuronium administration for tracheomalacia
Yano T., Taniguchi M., Tsuneyoshi I.
Journal of Anesthesia 29 ( 6 ) 978 2015.12
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (bulletin of university, research institution) Publisher：Journal of Anesthesia
Presentations 【 display / non-display 】
-
ICUでの術後輸液管理（教育セミナー）． Invited
矢野武志
第49回日本集中治療医学会学術集会
Event date： 2022.3.18 - 2022.3.20
Language：Japanese Presentation type：Public lecture, seminar, tutorial, course, or other speech
-
人工呼吸器HAMILTON-G5に内蔵された高流量酸素投与機能の使用経験．
村社瑞穂，長嶺佳弘，矢野武志，谷口正彦，恒吉勇男
日本臨床麻酔学会第41回大会
Event date： 2021.11.5 - 2021.11.7
Language：Japanese Presentation type：Oral presentation (general)
-
腹臥位療法後にICU-acquired weaknessを発症した重症COVID-19の１症例．
古澤高廣，矢野武志，村社瑞穂，深尾麻由，與那覇 哲，山下幸貴，谷口正彦，恒吉勇男
日本臨床麻酔学会第41回大会
Event date： 2021.11.5 - 2021.11.7
Language：Japanese Presentation type：Oral presentation (general)
-
人工呼吸の変革と成長―COVID-19で変わったこと（招請講演） Invited
矢野武志
九州麻酔科学会第59回大会
Event date： 2021.9.4 - 2021.10.4
Language：Japanese Presentation type：Public lecture, seminar, tutorial, course, or other speech
-
透析用ブラッドアクセスカテーテルが上行腰静脈に迷入し腸腰筋血腫を呈した１症例．
古澤高廣，矢野武志，村社瑞穂，深尾麻由，與那覇 哲，山下幸貴，谷口正彦，恒吉勇男
日本集中治療医学会第５回九州支部学術集会
Event date： 2021.7.24
Language：Japanese Presentation type：Oral presentation (general)
Grant-in-Aid for Scientific Research 【 display / non-display 】
-
重症敗血症における臓器リモデリングの検討
2015.04 - 2018.03
科学研究費補助金 基盤研究(C)
Authorship：Principal investigator
重症敗血症における臓器リモデリングの検討
-
敗血症性ショック治療薬としてのトロンボモデュリンの効果
2013.04 - 2015.03
科学研究費補助金 若手研究(B)
Authorship：Principal investigator
敗血症性ショック治療薬としてのトロンボモデュリンの効果
-
敗血症性ショックに対する新規治療薬の開発
2011.04 - 2013.03
科学研究費補助金 若手研究(B)
Authorship：Principal investigator
敗血症性ショックに対する新規治療薬の開発